Evidence map›Paper›PMID 32034291›Full record

ArticleMolecular psychiatry2021

DNA methylation signature on phosphatidylethanol, not on self-reported alcohol consumption, predicts hazardous alcohol consumption in two distinct populations.

Xiaoyu Liang, Amy C Justice, Kaku So-Armah, John H Krystal, Rajita Sinha, Ke Xu

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. RNA biomarkers for alcohol use disorder.Frontiers in molecular neuroscience · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaoyu LiangDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-7796-2441
Amy C JusticeVA Connecticut Healthcare System, West Haven, CT, USA.ORCID http://orcid.org/0000-0003-0139-5502
Kaku So-ArmahBoston University School of Medicine, Boston, MA, USA.
John H KrystalDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Rajita SinhaDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Ke XuDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA. ke.xu@yale.edu.
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Chronic Alcohol and Brain Stress Circuit ResponseR01AA013892 · NIAAA · YALE UNIVERSITY · PI Rajita Sinha · 2003 to 2026
$10.1M
Enhancing Discovery of HIV Host Genetics using Drug Abuse and other InteractionsR01DA038632 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI JOHNSON, ERIC OTTO · 2014 to 2018
$3.7M
Protocols, Statistics, Collaborative Method Development and ToolsPL1DA024859 · NIDA · YALE UNIVERSITY · PI SINHA, RAJITA · 2007 to 2011
$3.6M
Feature selection of DNA methylation biosignatures for neuropathy with comorbid drug abuse in the setting of HIV infectionR01DA047820 · NIDA · YALE UNIVERSITY · PI AOUIZERAT, BRADLEY E, XU, KE · 2018 to 2022
$2.9M
Defining the impact of injection drug use on antiretroviral therapy and HIV treatment outcomes: an (epi)genomic approachR01DA047063 · NIDA · YALE UNIVERSITY · PI AOUIZERAT, BRADLEY E, XU, KE · 2018 to 2022
$2.4M
Novel Mechanisms Driving Excess Atherosclerotic Cardiovascular Disease Risk in the Context of HIV: The Role of Liver InjuryK01HL134147 · NHLBI · BOSTON MEDICAL CENTER · PI SO-ARMAH, KAKU · 2016 to 2020
$620k
Genome-wide DNA methylation in HIV infected drug usersR03DA039745 · NIDA · YALE UNIVERSITY · PI XU, KE · 2015 to 2016
$260k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS K01 HL134147NIAAA NIH HHS R01 AA013892NIDA NIH HHS PL1 DA024859NIDA NIH HHS R01 DA038632NIDA NIH HHS R01 DA047063NIDA NIH HHS R01 DA047820NIDA NIH HHS R03 DA039745
6 · The paper itself

Abstract

The process of diagnosing hazardous alcohol drinking (HAD) is based on self-reported data and is thereby vulnerable to bias. There has been an interest in developing epigenetic biomarkers for HAD that might complement clinical assessment. Because alcohol consumption has been previously linked to DNA methylation (DNAm), we aimed to select DNAm signatures in blood to predict HAD from two demographically and clinically distinct populations (N

Indexed as

DNA MethylationGlycerophospholipidsAlcohol DrinkingBiomarkersHumansSelf ReportBiomarkersGlycerophospholipidsphosphatidylethanol

Identifiers

PMID32034291
PMCPMC8440221
OpenAlexW3005064158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.